C12Y 103/01093
Very-long-chain enoyl-coa reductase
Official title: Very-long-chain enoyl-CoA reductase (1.3.1.93)
C12Y103/01093 (Very-long-chain enoyl-coa reductase) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 5
- Assignees
- 3
- Inventors
- 18
- Latest grant
- 29 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Microorganisms and methods for the production of fatty acids and fatty acid derived products29 Oct 2024US 12,129,506 B2Cargill, Incorporated
- Microorganisms and methods for the production of fatty acids and fatty acid derived products9 Aug 2022US 11,408,013 B2Cargill, Incorporated
- Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion2 Apr 2019US 10,246,750 B2Blueprint Medicines Corporation
- Biosynthesis of dihydrochalcones and dihydrostilbenoids9 Jul 2026US 2026/0193680 A1Conagen Inc.
- Microorganisms and methods for the production of fatty acids and fatty acid derived products2 Feb 2023US 2023/0033275 A1Cargill, Incorporated
- Methods and genetically modified cells for production of fatty acid esters1 Oct 2020US 2020/0308613 A1Cargill, Incorporated
- Microorganisms and methods for the production of fatty acids and fatty acid derived products13 Feb 2020US 2020/0048666 A1Cargill, Incorporated
- Pkn1 fusions27 Apr 2017US 2017/0114417 A1Blueprint Medicines Corporation
Most cited
By later US patents